A tumor-associated glycoprotein that blocks MHC class II-dependent antigen presentation by dendritic cells

Journal of Immunology

Volumn 173, Issue 2, 2004, Pages 1023-1032

  Gutzmer, Ralf ^a,b   Li, Wei ^a   Sutterwala, Shaheen ^a   Lemos, Maria P ^a   Elizalde, J Ignasi ^a   Urtishak, Sandra L ^a   Behrens, Edward M ^a   Rivers, Patricia M ^a   Schlienger, Katia ^a   Laufer, Terri M ^a   Eck, Stephen L ^a,c   Marks, Michael S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD8 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MOUSE EPITHELIAL GLYCOPROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BONE MARROW; BREAST; COLON; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOSURVEILLANCE; LUNG; MIXED LYMPHOCYTE REACTION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TUMOR ESCAPE;

EID: 3142675735     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.2.1023     Document Type: Article

References (64)

1. Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725.
2. Seliger, B., M. J. Maeurer, and S. Ferrone. 2000. Antigen-processing machinery breakdown and tumor growth. Immunol. Today 21:455.
3. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323.
4. + T cell responses in antitumor immunity. Curr. Opin. Immunol. 10:588.
5. Kawakami, Y., and S. A. Rosenberg. 1997. Human tumor antigens recognized by T-cells. Immunol. Res. 16:313.
6. + T cells in antitumor immunity. Trends Immunol. 22:269.
7. Robbins, P. F., M. El-Gamil, Y. F. Li, G. Zeng, M. Dudley, and S. A. Rosenberg. 2002. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma. J. Immunol. 169:6036.
8. Rosenberg, S. A. 1999. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 10:281.
9. Wang, R. F., X. Wang, A. C. Atwood, S. L. Topalian, and S. A. Rosenberg. 1999. Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. Science 284:1351.
10. + T cells in cancer immunotherapy. Curr. Opin. Immunol. 6:741.
11. + T cells in the antitumor immune response. J. Exp. Med. 188:2357.
12. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
13. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
14. + T-helper and a T-killer cell. Nature 393:474.
15. -/- dendritic cells to provide tumor protection is rescued by CD40 ligation. J. Immunol. 163:77.
16. Ostrand-Rosenberg, S. 1994. Tumor immunotherapy: the tumor cell as an antigen-presenting cell. Curr. Opin. Immunol. 6:722.
17. Mellman, I., S. J. Turley, and R. M. Steinman. 1998. Antigen processing for amateurs and professionals. Trends Cell Biol. 8:231.
18. Linnenbach, A. J., J. Wojcierowski, S. A. Wu, J. J. Pyrc, A. H. Ross, B. Dietzschold, D. Speicher, and H. Koprowski. 1989. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733. Proc. Natl. Acad. Sci. USA 86:27.
19. Bergsagel, P. L., C. Victor-Kobrin, C. R. Timblin, J. Trepel, and W. M. Kuehl. 1992. A murine cDNA encodes a pan-epithelial glycoprotein that is also expressed on plasma cells. J. Immunol. 148:590.
20. r 34,000 is a widely distributed human carcinoma marker. Br. J. Cancer 56:714.
21. Momburg, F., G. Moldenhauer, G. J. Hammerling, and P. Moller. 1987. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res. 47:2883.
22. Braun, S., F. Hepp, H. L. Sommer, and K. Pantel. 1999. Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease. Int. J. Cancer 84:1.
23. Litvinov, S. V., M. P. Velders, H. A. Bakker, G. J. Fleuren, and S. O. Warnaar. 1994. Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J. Cell Biol. 125:437.
24. Litvinov, S. V., M. Balzar, M. J. Winter, H. A. Bakker, I. H. Briaire-de Bruijn, F. Prins, G. J. Fleuren, and S. O. Warnaar. 1997. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J. Cell Biol. 139:1337.
25. Zaloudik, J., S. Basak, M. Nesbit, D. W. Speicher, W. H. Wunner, E. Miller, C. Ernst-Grotkowski, R. Kennedy, L. P. Bergsagel, T. Koido, and D. Herlyn. 1997. Expression of an antigen homologous to the human CO17-1A/GA733 colon cancer antigen in animal tissues. Br. J. Cancer 76:909.
26. Shurin, M. R., P. P. Pandharipande, T. D. Zorina, C. Haluszczak, V. M. Subbotin, O. Hunter, A. Brumfield, W. J. Storkus, E. Maraskovsky, and M. T. Lotze. 1997. FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell. Immunol. 179:174.
27. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
28. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76:34.
29. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
30. Boxhorn, H. K., J. G. Smith, Y. J. Chang, D. Guerry, W. M. Lee, U. Rodeck, L. A. Turka, and S. L. Eck. 1998. Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors. Cancer Immunol. Immunother. 46:283.
31. Wells, A. D., H. Gudmundsdottir, and L. A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion: signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100:3173.
32. Gudmundsdottir, H., A. D. Wells, and L. A. Turka. 1999. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J. Immunol. 162:5212.
33. + T cells by monocyte-derived dendritic cells. Blood 96:3490.
34. Schlienger, K., C. S. Chu, E. Y. Woo, P. M. Rivers, A. J. Toll, B. Hudson, M. V. Maus, J. L. Riley, Y. Choi, G. Coukos, et al. 2003. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin. Cancer Res. 9:1517.
35. Borkowski, T. A., A. J. Nelson, A. G. Farr, and M. C. Udey. 1996. Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells. Eur. J. Immunol. 26:110.
36. lo thymocytes in vivo. Science 250:1720.
37. + T cells. J. Exp. Med. 179:1539.
38. + T cells is amplified by prolonged T cell antigen receptor triggering. J. Exp. Med. 196:793.
39. Steinman, R. M., and J. Swanson. 1995. The endocytic activity of dendritic cells. J. Exp. Med. 182:283.
40. Inaba, K., S. Turley, F. Yamaide, T. Iyoda, K. Mahnke, M. Inaba, M. Pack, M. Subklewe, B. Sauter, D. Sheff, et al. 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188:2163.
41. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86.
42. Albert, M. L., S. F. Pearce, L. M. Francisco, B. Sauter, P. Roy, R. L. Silverstein, and N. Bhardwaj. 1998. Immature dendritic cells phagocytose apoptotic cells via αβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359.
43. Yue, F. Y., R. Dummer, R. Geertsen, G. Hofbauer, E. Laine, S. Manolio, and G. Burg. 1997. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-1, HLA class-II and ICAM-1 molecules. Int. J. Cancer 71:630.
44. Matsuda, M., F. Salazar, M. Petersson, G. Masucci, J. Hansson, P. Pisa, Q. J. Zhang, M. G. Masucci, and R. Kiessling. 1994. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and down-regulates HLA class I expression. J. Exp. Med. 180:2371.
45. Zou, J. P., L. A. Mofford, C. Chougnet, A. R. Dix, A. G. Brooks, N. Torres, J. D. Shuman, J. E. Coligan, W. H. Brooks, T. L. Roszman, and G. M. Shearer. 1999. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers. J. Immunol. 162:4882.
46. Antonia, S. J., M. Extermann, and R. A. Flavell. 1998. Immunologic nonresponsiveness to tumors. Crit. Rev. Oncog. 9:35.
47. Garrido, F., T. Cabrera, A. Concha, S. Glew, F. Ruiz-Cabello, and P. L. Stern. 1993. Natural history of HLA expression during tumour development. Immunol. Today 14:491.
48. Seliger, B., M. J. Maeurer, and S. Ferrone. 1997. TAP off-tumors on. Immunol. Today 18:292.
49. Hengel, H., and U. H. Koszinowski. 1997. Interference with antigen processing by viruses. Curr. Opin. Immunol. 9:470.
50. Ploegh, H. L. 1998. Viral strategies of immune evasion. Science 280:248.
51. Gabrilovich, D. I., J. Corak, I. F. Ciernik, D. Kavanaugh, and D. P. Carbone. 1997. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3:483.
52. Chaux, P., N. Favre, M. Martin, and F. Martin. 1997. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int. J. Cancer 72:619.
53. Koppelman, B., J. J. Neefjes, J. E. de Vries, and R. de Waal Malefyt. 1997. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7:861.
54. + T cells. Nat. Med. 5:1039.
55. Gastl, G., G. Spizzo, P. Obrist, M. Dunser, and G. Mikuz. 2000. Ep-CAM over-expression in breast cancer as a predictor of survival. Lancet 356:1981.
56. Lem, L., D. A. Riethof, M. Scidmore-Carlson, G. M. Griffiths, T. Hackstadt, and F. M. Brodsky. 1999. Enhanced interaction of HLA-DM with HLA-DR in enlarged vacuoles of hereditary and infectious lysosomal diseases. J. Immunol. 162:523.
57. Hmama, Z., R. Gabathuler, W. A. Jefferies, G. de Jong, and N. E. Reiner. 1998. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. Immunol. 161:4882.
58. Koch, N., W. Lauer, J. Habicht, and B. Dobberstein. 1987. Primary structure of the gene for the murine Ia antigen-associated invariant chains (II): an alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J. 6:1677.
59. Strubin, M., C. Berte, and B. Mach. 1986. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J. 5:3483.
60. O'Sullivan, D. M., D. Noonan, and V. Quaranta. 1987. Four Ia invariant chain forms derive from a single gene by alternative splicing and alternative initiation of transcription/translation. J. Exp. Med. 166:444.
61. Guncar, G., G. Pungercic, I. Klemencic, V. Turk, and D. Turk. 1999. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J. 18:793.
62. Fineschi, B., L. S. Arneson, M. F. Naujokas, and J. Miller. 1995. Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41. Proc. Natl. Acad. Sci. USA 92:10257.
63. Fineschi, B., K. Sakaguchi, E. Appella, and J. Miller. 1996. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain. J. Immunol. 157:3211.
64. Balzar, M., H. A. Bakker, I. H. Briaire-de-Bruijn, G. J. Fleuren, S. O. Warnaar, and S. V. Litvinov. 1998. Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule. Mol. Cell. Biol. 18:4833.